Search research articles
Contact Us
Filters
Showing results (1-10 of 87) with videos related to
Page
of 9
Sort By:
Nihon Jinzo Gakkai Shi
|
September 29, 2007
[Polycystic kidney disease]
Eiji Higashihara
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
September 28, 2005
[Urological cancer]
Moriaki Kato, Eiji Higashihara
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
July 15, 2004
[Urolithiasis in hemodialysis patients]
Kikuo Nutahara, Eiji Higashihara
The Journal of Urology
|
August 19, 2008
Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer
Takatsugu Okegawa, Kikuo Nutahara, Eiji Higashihara
Current Urology Reports
|
June 27, 2002
Laparoscopic adrenalectomy: alternative or new standard?
Eiji Higashihara, Kikuo Nutahara, Moriaki Kato
Expert Opinion on Pharmacotherapy
|
May 22, 2024
Juxtaglomerular apparatus-mediated homeostatic mechanisms: therapeutic implication for chronic kidney disease
Eiji Higashihara, Takeo Harada, Hiroshi Fukuhara
International Journal of Urology : Official Journal of the Japanese Urological Association
|
September 3, 2010
Alternative antiandrogen therapy in patients with castration-resistant prostate cancer: a single-center experience
Takatsugu Okegawa, Kikuo Nutahara, Eiji Higashihara
The Journal of Urology
|
January 20, 2009
Prognostic significance of circulating tumor cells in patients with hormone refractory prostate cancer
Takatsugu Okegawa, Kikuo Nutahara, Eiji Higashihara
International Journal of Urology : Official Journal of the Japanese Urological Association
|
March 27, 2010
Association of circulating tumor cells with tumor-related methylated DNA in patients with hormone-refractory prostate cancer
Takatsugu Okegawa, Kikuo Nutahara, Eiji Higashihara
Clinical and Experimental Nephrology
|
January 3, 2025
Change in kidney volume growth rate and renal outcomes of tolvaptan treatment in autosomal dominant polycystic kidney disease: post-hoc analysis of TEMPO 3:4 trial
Eiji Higashihara, Miyuki Matsukawa, Huan Jiang
Page
of 9
Search research articles
Search
Showing results (1-10 of 87) with videos related to
Sort By:
Page
of 9
Nihon Jinzo Gakkai Shi
|
September 29, 2007
[Polycystic kidney disease]
Eiji Higashihara
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
September 28, 2005
[Urological cancer]
Moriaki Kato, Eiji Higashihara
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
July 15, 2004
[Urolithiasis in hemodialysis patients]
Kikuo Nutahara, Eiji Higashihara
The Journal of Urology
|
August 19, 2008
Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer
Takatsugu Okegawa, Kikuo Nutahara, Eiji Higashihara
Current Urology Reports
|
June 27, 2002
Laparoscopic adrenalectomy: alternative or new standard?
Eiji Higashihara, Kikuo Nutahara, Moriaki Kato
Expert Opinion on Pharmacotherapy
|
May 22, 2024
Juxtaglomerular apparatus-mediated homeostatic mechanisms: therapeutic implication for chronic kidney disease
Eiji Higashihara, Takeo Harada, Hiroshi Fukuhara
International Journal of Urology : Official Journal of the Japanese Urological Association
|
September 3, 2010
Alternative antiandrogen therapy in patients with castration-resistant prostate cancer: a single-center experience
Takatsugu Okegawa, Kikuo Nutahara, Eiji Higashihara
The Journal of Urology
|
January 20, 2009
Prognostic significance of circulating tumor cells in patients with hormone refractory prostate cancer
Takatsugu Okegawa, Kikuo Nutahara, Eiji Higashihara
International Journal of Urology : Official Journal of the Japanese Urological Association
|
March 27, 2010
Association of circulating tumor cells with tumor-related methylated DNA in patients with hormone-refractory prostate cancer
Takatsugu Okegawa, Kikuo Nutahara, Eiji Higashihara
Clinical and Experimental Nephrology
|
January 3, 2025
Change in kidney volume growth rate and renal outcomes of tolvaptan treatment in autosomal dominant polycystic kidney disease: post-hoc analysis of TEMPO 3:4 trial
Eiji Higashihara, Miyuki Matsukawa, Huan Jiang
Page
of 9